Pain chronification risk assessment: advanced phenotyping and scoring for prediction and treatments tailored to individualized patient profile
- PMID: 39635026
- PMCID: PMC11612039
- DOI: 10.1007/s13167-024-00383-3
Pain chronification risk assessment: advanced phenotyping and scoring for prediction and treatments tailored to individualized patient profile
Abstract
Acute pain is a physiologic, protective life-important warning neurological signal indicating multi-level tissue modulations caused by a broad spectrum of health adverse events such as stress overload, mechanical trauma, ischemia-reperfusion, sterile and infection-triggered inflammation, single- and multi-organ damage, acute and chronic wounds, tissue remodeling and degeneration, amongst others. On the other hand, pain chronification results in a pathologic transformation from the protective pain signaling into persistent debilitative medical condition with severe consequences including but not restricted to phenotype-specific behavioral patterns, reduced quality of life, and cognitive and mood disorders. Who is predisposed to an increased vs. decreased pain sensitivity and to the pain chronification? The motivation of personalized medicine that "same size does not fit all" is getting obvious also for an advanced approach in algesiology. Consequently, an in-depth patient stratification is essential for the paradigm change in overall pain management from currently applied reactive medical services to the cost-effective predictive, preventive, and personalized medicine (PPPM/3PM) in primary (reversible damage to health and targeted protection against health-to-disease transition) and secondary (personalized protection against disease progression) care. To this end, specifically innovative concepts of phenotyping elaborated in this study play a crucial role in patient stratification for predicting pain-associated outcomes, evidence-based targeted prevention of the pain chronification, and creation of treatment algorithms tailored to individualized patient profiles.
Supplementary information: The online version contains supplementary material available at 10.1007/s13167-024-00383-3.
Keywords: Algesiology; Chronic pain; Diabetes; Flammer syndrome; Health policy; Health-to-disease transition; Low-grade inflammation; Mitochondria; Pain chronification prediction; Pain perception and sensitivity; Patient stratification; Personalized protection; Phenotyping; Predictive preventive personalized medicine (PPPM/3PM); Primary and secondary care; Questionnaire; Risk assessment; Scoring; Shifted regulation; Survey; Systemic risks.
© The Author(s) 2024.
Conflict of interest statement
Conflict of interestThe authors declare no competing interests.
Figures
Similar articles
-
Mitochondrial medicine: "from bench to bedside" 3PM-guided concept.EPMA J. 2025 Apr 15;16(2):239-264. doi: 10.1007/s13167-025-00409-4. eCollection 2025 Jun. EPMA J. 2025. PMID: 40438494 Free PMC article.
-
Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.EPMA J. 2024 Apr 8;15(2):289-319. doi: 10.1007/s13167-024-00357-5. eCollection 2024 Jun. EPMA J. 2024. PMID: 38841622 Free PMC article. Review.
-
3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation.EPMA J. 2024 Oct 31;15(4):677-692. doi: 10.1007/s13167-024-00381-5. eCollection 2024 Dec. EPMA J. 2024. PMID: 39635024 Free PMC article.
-
Acute mountain sickness prediction: a concerto of multidimensional phenotypic data and machine learning strategies in the framework of predictive, preventive, and personalized medicine.EPMA J. 2025 Mar 31;16(2):265-284. doi: 10.1007/s13167-025-00404-9. eCollection 2025 Jun. EPMA J. 2025. PMID: 40438497 Free PMC article.
-
Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes.EPMA J. 2023 Dec 6;14(4):673-696. doi: 10.1007/s13167-023-00348-y. eCollection 2023 Dec. EPMA J. 2023. PMID: 38094577 Free PMC article. Review.
Cited by
-
Mitochondrial medicine: "from bench to bedside" 3PM-guided concept.EPMA J. 2025 Apr 15;16(2):239-264. doi: 10.1007/s13167-025-00409-4. eCollection 2025 Jun. EPMA J. 2025. PMID: 40438494 Free PMC article.
References
-
- Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TKS, de Clerck E, Polivka J Jr, Potuznik P, Polivka J, Stetkarova I, Kubatka P, Thumann G. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14(1):21–42. 10.1007/s13167-023-00314-8. - PMC - PubMed
-
- Golubnitschaja O, Polivka J Jr, Potuznik P, Pesta M, Stetkarova I, Mazurakova A, Lackova L, Kubatka P, Kropp M, Thumann G, Erb C, Fröhlich H, Wang W, Baban B, Kapalla M, Shapira N, Richter K, Karabatsiakis A, Smokovski I, Schmeel LC, Gkika E, Paul F, Parini P, Polivka J. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation. EPMA J. 2024;15(1):1–23. 10.1007/s13167-024-00356-6. - PMC - PubMed
LinkOut - more resources
Full Text Sources